Kole Roybal, PhD Director, PICI Center at UCSF; Associate Professor of Microbiology and Immunology Biography Kole Roybal, PhD, is the Center Director of the UCSF Parker Institute for Cancer Immunotherapy and an Associate Professor in the Department of Immunology at the UCSF. The Roybal Lab harnesses synthetic biology and immunology to increase the therapeutic potential of engineered immune cells. He was awarded the Sartorius and Science Magazine Prize for Regenerative Medicine and Cell Therapy, the NIH New Innovator Award, and the CRI STAR Award. His work was foundational to the next-generation immune cell therapy company, Cell Design Labs, where he was a founding scientist (acquired by Gilead). He has also co-founded cell therapy companies Arsenal Bio (now clinical stage), Dispatch Biotherapeutics, and Moonlight Bio focused on the treatment of solid tumors. Education & Training 2013: University of Texas Southwestern Medical Center, PhD, Immunology 2005: Austin College, TX, BA Biology